Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies

Cancer immune evasion, immunoediting and intratumour heterogeneity

Rejection of immunogenic tumor clones is limited by clonal fraction

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells